Found: 5
Select item for more details and to access through your institution.
Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice.
- Published in:
- International Journal of Cancer, 2000, v. 87, n. 1, p. 101, doi. 10.1002/1097-0215(20000701)87:1<101::AID-IJC15>3.0.CO;2-B
- By:
- Publication type:
- Article
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation.
- Published in:
- International Journal of Cancer, 1998, v. 76, n. 4, p. 579, doi. 10.1002/(SICI)1097-0215(19980518)76:4<579::AID-IJC22>3.0.CO;2-1
- By:
- Publication type:
- Article
Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance.
- Published in:
- International Journal of Cancer, 1996, v. 68, n. 4, p. 493, doi. 10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6
- By:
- Publication type:
- Article
Cyclophosphamide plus tumor necrosis factor-α chemoimmunotherapy cured mice: Life-long immunity and rejection of re-implanted primary lymphoma.
- Published in:
- International Journal of Cancer, 1995, v. 63, n. 3, p. 463, doi. 10.1002/ijc.2910630327
- By:
- Publication type:
- Article
Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 1, p. 83, doi. 10.1002/ijc.2910590117
- By:
- Publication type:
- Article